Millar Ja
Impact in
-
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
- Heart Rate Variability and Autonomic Control
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Blood Pressure and Hypertension Studies 2
- Cardiovascular Effects of Exercise 1
- Cardiovascular Health and Disease Prevention 1
-
- Health Systems, Economic Evaluations, Quality of Life 2
- Pharmaceutical Economics and Policy 2
- Co-authors
- Gerald F. Watts (1 shared paper)Sheila F. O’Brien (1 shared paper)William Silvester (1 shared paper)Michael Millward (1 shared paper)Wilson Pd (2 shared papers)V. Burke (1 shared paper)A. M. M. Cumming (1 shared paper)J. I. S. Robertson (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (1 paper)PharmacoEconomics (1 paper)Clinical Science (1 paper)Clinical and Experimental Pharmacology and Physiology (1 paper)Journal of Human Hypertension (1 paper)
- Partner nations
- AustraliaNew ZealandUnited Kingdom
In The Last Decade
Millar Ja
20 papers receiving 341 citations
Peers
Comparison fields: 5 of 59
- Cardiology and Cardiovascular Medicine 136
- Endocrinology, Diabetes and Metabolism 51
- Physiology 74
- Obstetrics and Gynecology 15
- Clinical Biochemistry 13
Countries citing papers authored by Millar Ja
This map shows the geographic impact of Millar Ja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Millar Ja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Millar Ja more than expected).
Fields of papers citing papers by Millar Ja
This network shows the impact of papers produced by Millar Ja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Millar Ja. The network helps show where Millar Ja may publish in the future.
Co-authors
The 14 scholars most cited alongside Millar Ja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 175 | |
| 2 | 2007 | 52 | |
| 3 | Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition. | 1980 | 35 |
| 4 | Enalapril and autonomic reflexes and exercise performance. | 1983 | 20 |
| 5 | Management of severe hypertension in pregnancy by a combined drug regimen including captopril: case report. | 1983 | 14 |
| 6 | Measurement of blood pressure may be affected by an interaction between subject and observer based on gender. | 1996 | 12 |
| 7 | 2002 | 9 | |
| 8 | 1984 | 8 | |
| 9 | The Cockroft and Gault formula for estimation of creatinine clearance: a friendly deconstruction. | 2012 | 8 |
| 10 | Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition. | 1980 | 6 |
| 11 | Evidence against a circulating ouabain-like transport inhibitor as a cause of increased red cell sodium in essential hypertension. | 1984 | 5 |
| 12 | 1982 | 4 | |
| 13 | 1998 | 2 | |
| 14 | 1995 | 2 | |
| 15 | Measurement of erythrocyte sodium and calcium efflux kinetics in man, and application to hypertension. | 1985 | 2 |
| 16 | Captopril as adjunctive treatment in catamenial epilepsy. | 1991 | 2 |
| 17 | Confounding factors in the study of membrane pump abnormalities in essential hypertension and pregnancy-induced hypertension. | 1988 | 1 |
| 18 | Adjustment of the apparent benefits of treatment on stroke risk in the MRC mild hypertension trial using data from the placebo-treated group. | 1995 | 1 |
| 19 | Current treatment of hypertension. Part 1: Diagnosis and nonpharmacological therapy. | 1992 | 1 |
| 20 | Current treatment of hypertension. Part 2: Risk factors, drug treatment and economic aspects. | 1992 | 1 |
About Millar Ja
Millar Ja is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics, Molecular Biology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 20 papers that have together received 360 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (2 papers), Pregnancy and preeclampsia studies (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Pharmaceutical Economics and Policy (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Cardiovascular Effects of Exercise (1 paper), Ion Transport and Channel Regulation (1 paper) and Cardiovascular Health and Disease Prevention (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (136 citations), Endocrinology, Diabetes and Metabolism (51 citations), Physiology (74 citations), Obstetrics and Gynecology (15 citations) and Clinical Biochemistry (13 citations). Millar Ja has collaborated with scholars based in Australia, New Zealand and United Kingdom. Frequent co-authors include Gerald F. Watts, Sheila F. O’Brien, William Silvester, Michael Millward, Wilson Pd, V. Burke, A. M. M. Cumming, J. I. S. Robertson, P A Mason and Simpson Fo. Their work appears in journals such as British Journal of Clinical Pharmacology, PharmacoEconomics, Clinical Science, Clinical and Experimental Pharmacology and Physiology and Journal of Human Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.